Buprenorphine Market Size and Trends

Buprenorphine Market, By Application (Analgesic, Opioid Antagonist), By Route of Administration (Injectables, Sublingual, Transdermal), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Published In : Nov 2023

Code : CMI4237

Pages :180

Formats :

Excel and PDF

Industry : Pharmaceutical

Buprenorphine MarketSize and Trends

The global buprenorphine market is estimated to be valued at US$ 5.52 Billion in 2023 and is expected to exhibit a CAGR of 14.9% during the forecast period (2023-2030).

Figure 1. Global Buprenorphine Market Share (%), by Application, 2023

Global Buprenorphine Market – Driver

Approval of Buprenorphine Treatment for Opioid Use Disorder, by Regulatory Authorities

Increasing approval of buprenorphine treatment for opioid use disorder by regulatory authorities is expected to drive the growth of the global buprenorphine market over the forecast period. For instance, on May 23, 2023, the U.S. Food and Drug Administration approved Brixadi (buprenorphine) extended-release injection for subcutaneous use to treat moderate to severe opioid use disorder. Brixadi is available in two formulations: a weekly injection...

Figure 2. Global Buprenorphine Market Share (%), by Region, 2023

Global Buprenorphine Market – Market-Trends

Based on application, the market is segmented into analgesic and opioid antagonist. Out of which, the opioid antagonist segment is expected to hold a dominant position...